Classification Information
Plant extracts for pharmaceutical purposes, hemostatics for medical purposes; pharmaceuticals, namely, pharmaceuticals for the treatment of nausea, anxiety, pain, glaucoma, seizures, multiple sclerosis and Crohn's Disease; to the extent any of the foregoing involves cannabis, such cannabis shall have a delta-9 THC concentration of not more than 0.3% on a dry weight basis and none of the foregoing containing CBD
Pharmaceuticals